NASDAQ:VTGN | Free Cash Flow | Vistagen Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-06-30 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30-$14.71M
2026-03-31-$16.2M
2025-06-30-$18.85M
2025-03-31-$10.06M
2024-06-30-$10.87M
2024-03-31-$6.99M
2023-06-30-$7.89M
2023-03-31-$7.47M
2022-06-30-$15.97M$175,100.00-$16.14M
2022-03-31-$15.59M$100.00-$15.59M
2021-06-30-$6.17M$149,900.00-$6.32M
2021-03-31-$5.28M$25,500.00-$5.31M
2020-06-30-$2.81M$0.00-$2.81M
2020-03-31-$2.58M
2019-06-30-$4.76M
2019-03-31-$3.56M$174,000.00-$3.73M
2018-06-30-$3.14M
2018-03-31-$2.6M$0.00-$2.6M
2017-06-30-$2.13M
2017-03-31-$1.29M
2016-06-30-$1.67M
2016-03-31-$1.31M
2015-06-30-$823,300.00
2015-03-31-$894,500.00
2014-06-30-$1.01M
2014-03-31-$467,100.00
2013-06-30-$731,800.00
2013-03-31-$970,000.00
2012-06-30-$296,200.00
2012-03-31-$718,600.00
2011-06-30-$1.09M
2011-03-31-$90,415.00
2010-06-30-$325,320.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$66.44M
2025-03-31-$42.1M
2024-03-31-$25.81M
2023-03-31-$49.72M
2022-03-31-$45.26M$200,400.00-$45.46M
2021-03-31-$12.07M$275,400.00-$12.35M
2020-03-31-$15.76M$0.00-$15.76M
2019-03-31-$14.53M$174,000.00-$14.7M
2018-03-31-$9.06M$1,600.00-$9.06M
2017-03-31-$7.26M$239,100.00-$7.5M
2016-03-31-$4.81M$26,300.00-$4.83M
2015-03-31-$2.77M
2014-03-31-$2.13M
2013-03-31-$3.46M
2012-03-31-$3.57M
2011-03-31-$841,300.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.